Instacare announces filing of patent application for MD@Hand technologies

Instacare Corp. (OTC Bulletin Board: ISCR), a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that on Friday, February 26, 2010, the Company filed a Provisional Patent Application to secure its MD@Hand technologies. The patent is titled "Information Management And Communications System And Method."  The company has received appropriate serial numbers from the U.S. Patent and Trademarks Office recognizing the filing and the filing date.

Keith Berman, CFO of Instacare commented, "Now that we have a patent application on file, and additional applications forthcoming, we will shortly engage an intellectual properties expert to provide the company with a third party evaluation of the value in use of our technologies. This study is a major part of our initiative to achieve a listing on the NYSE-Amex."

The Company plans to file additional applications, one covering its MD@Practice-Probe technologies, a separate patent for the Company's base communication technology for world-wide communication between cell phones and health data repositories and a third additional patent for its Medical Game Theory Methods and Processes.

Robert Jagunich, Chairman of Instacare commented, "After careful consultation with our intellectual property counsel, we elected to file a Provisional Patent instead of a Full Utility Patent because of ongoing ambiguity from the U.S. Supreme Court regarding patents on processes related to software. While we do not feel that any upcoming Supreme Court ruling will affect our MD@Hand claims, which make use of the company's proprietary securitized EMR storage device, the steps we have taken protect the company and its shareholders from efforts by patent trolls and copy-cats."

SOURCE Instacare Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes rates skyrocket globally with millions left untreated